Eric Chapman, PhD

Eric Chapman, PhD has a diverse work experience. Eric currently works at Lifescience Dynamics Limited as a Senior Business Analyst, a position they have held since August 2022. Prior to this, they worked as a Business Analyst at the same company from May 2021 to July 2022.

Before joining Lifescience Dynamics Limited, Eric worked at GlobalData Healthcare. Eric started as an Analyst in February 2019 and was promoted to Senior Analyst in August 2020. In this role, they managed a team of 7 associate and junior analysts and conducted market analysis and forecasting in various healthcare markets. Eric also worked closely with clients and stakeholders, presented seminars, and analyzed market trends in robotic surgery.

Eric's earlier experience includes working as a PhD candidate at The Hospital for Sick Children from January 2013 to September 2018. During their time there, they researched Cerebral Cavernous Malformations (CCM) disease and the cellular response to radiation.

Eric also served as the Vice President of the Graduate Student Association at the Department of Molecular Genetics from January 2016 to January 2018. In this role, they managed executive members, coordinated the Ambassador Program, and participated in the hiring process for a new Assistant Professor.

Furthermore, Eric worked as a Teaching Assistant at the University of Toronto from September 2017 to December 2017, and as a Research Scholar at the Strategic Training in Radiation Science program supported by the Terry Fox Foundation from September 2014 to September 2016.

Overall, Eric Chapman, PhD has extensive experience in business analysis, market research, scientific research, and leadership roles.

Eric Chapman, PhD, completed their undergraduate education at Queen's University from 2008 to 2012. During this time, they obtained a Bachelor of Science (Honors) degree in Molecular Biology. Following their undergraduate studies, Eric pursued further education at the University of Toronto from 2012 to 2018. At this institution, they earned a Doctor of Philosophy (PhD) degree in Molecular Genetics.